LIANY LianBio

Fundamentals / CIK 0001831283 / USD

LianBio reported $262.9M in total assets and a net loss of $87.98M through December 31, 2022 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LIANY in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2020 to 2022), reported in USD.

$0$0$0-$183.5MFY 2020 Net Income: -$139.6M2020FY 2021 Net Income: -$196.3M2021FY 2022 Net Income: -$110.3M2022

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Research & Development $59.76M $158.7M $120.9M
Total Operating Expenses $125.4M $195.6M $134.9M
Operating Income -$125.4M -$195.6M -$134.9M
EBITDA -$124.3M -$195.0M -$134.8M
Income Before Tax -$110.6M -$195.8M -$139.6M
Income Tax Expense -$333K $518K $4.0K
Net Income -$110.3M -$196.3M -$139.6M
Basic EPS -$1.02 -$5.71 -$11.58
Diluted EPS -$1.02 -$5.71 -$11.58
Basic Shares Outstanding 107.9M 34.4M 12.1M
Diluted Shares Outstanding 107.9M 34.4M 12.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31
Research & Development $9.02M $9.45M $10.83M $10.58M $8.26M $28.59M $12.33M $7.65M
Total Operating Expenses $26.30M $25.04M $25.97M $29.25M $24.55M $43.14M $28.42M $22.04M
Operating Income -$26.30M -$25.04M -$25.97M -$29.25M -$24.55M -$43.14M -$28.42M -$22.04M
EBITDA -$26.00M -$24.74M -$25.64M -$28.93M -$24.35M -$42.94M -$28.15M -$21.79M
Income Tax Expense $586K $200K $438K -$350K $6.0K $5.0K $6.0K -$1.03M
Net Income -$24.04M -$21.62M -$24.05M -$18.28M -$21.90M -$42.39M -$27.73M -$21.20M
Basic EPS -$0.22 -$0.20 -$0.22 -- -$0.20 -$0.39 -$0.26 --
Diluted EPS -$0.22 -$0.20 -$0.22 -- -$0.20 -$0.39 -$0.26 --
Basic Shares Outstanding 107.2M 107.2M 107.2M -- 108.4M 107.9M 107.3M --
Diluted Shares Outstanding 107.2M 107.2M 107.2M -- 108.4M 107.9M 107.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $79.22M $228.2M $254.3M
Short-Term Investments $223.1M $155.1M $0
Cash & Short-Term Investments $302.4M $383.2M $254.4M
Total Current Assets $312.8M $399.6M $276.7M
Property, Plant & Equipment, Net $3.12M $1.88M $822K
Other Non-Current Assets $20K $51K $12K
Total Non-Current Assets $7.19M $26.70M $2.54M
Total Assets $320.0M $426.3M $279.3M
Accounts Payable $1.45M $3.23M $4.33M
Other Current Liabilities $485K $760K $360K
Total Current Liabilities $23.61M $15.09M $6.23M
Other Non-Current Liabilities $210K $206K $0
Total Non-Current Liabilities $2.70M $23.91M $21.34M
Total Liabilities $26.31M $39.01M $27.57M
Total Debt (incl. Leases) $4.34M $4.83M $1.88M
Common Stock $2.0K $2.0K $0
Retained Earnings -$470.5M -$360.2M -$163.9M
Accumulated Other Comp. Income -$2.08M $526K -$40K
Total Stockholders' Equity $259.9M $353.6M -$132.8M
Total Equity $293.6M $387.3M -$98.07M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31
Cash & Cash Equivalents $103.5M $104.1M $102.3M $79.22M $78.86M $134.3M $139.9M $228.2M
Short-Term Investments $148.8M $163.2M $184.2M $223.1M $232.9M $195.0M $229.3M $155.1M
Cash & Short-Term Investments $252.2M $267.3M $286.5M $302.4M $311.7M $329.3M $369.1M $383.2M
Total Current Assets $257.8M $273.1M $296.1M $312.8M $324.2M $343.7M $386.1M $399.6M
Property, Plant & Equipment, Net $2.36M $2.56M $2.84M $3.12M $3.13M $2.99M $2.92M $1.88M
Other Non-Current Assets $20K $20K $20K $20K $37K $39K $50K $51K
Total Non-Current Assets $5.10M $5.70M $6.53M $7.19M $27.60M $28.11M $27.34M $26.70M
Total Assets $262.9M $278.8M $302.6M $320.0M $351.8M $371.8M $413.5M $426.3M
Accounts Payable $6.23M $1.91M $5.43M $1.45M $2.02M $1.23M $7.93M $3.23M
Other Current Liabilities $1.62M $996K $1.96M $485K $387K $738K $979K $760K
Total Current Liabilities $25.63M $21.64M $25.93M $23.61M $22.03M $21.75M $25.15M $15.09M
Other Non-Current Liabilities $213K $210K $217K $210K $200K $208K $207K $206K
Total Non-Current Liabilities $1.16M $1.65M $2.23M $2.70M $23.22M $23.87M $23.55M $23.91M
Total Liabilities $26.79M $23.29M $28.16M $26.31M $45.24M $45.62M $48.71M $39.01M
Total Debt (incl. Leases) $2.84M $3.30M $3.92M $4.34M $4.77M $5.46M $4.72M $4.83M
Common Stock $2.0K $2.0K $2.0K $2.0K $2.0K $2.0K $2.0K $2.0K
Retained Earnings -$540.2M -$516.2M -$494.6M -$470.5M -$452.2M -$430.4M -$388.0M -$360.2M
Accumulated Other Comp. Income -$3.22M -$3.33M -$1.53M -$2.08M -$3.84M -$1.40M -$690K $526K
Total Stockholders' Equity $202.3M $221.7M $240.7M $259.9M $272.8M $292.4M $331.0M $353.6M
Total Equity $236.1M $255.5M $274.4M $293.6M $306.6M $326.2M $364.8M $387.3M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$110.3M -$196.3M -$139.6M
Depreciation & Amortization $1.01M $525K $76K
Stock-Based Compensation $19.15M $8.66M $5.18M
Change in Payables -$1.71M -$1.71M $4.16M
Operating Cash Flow -$99.19M -$164.0M -$98.14M
Capital Expenditure -$1.84M -$947K -$886K
Free Cash Flow -$101.0M -$164.9M -$99.03M
Purchases of Investments -$303.1M -$155.0M $0
Investing Cash Flow -$69.20M -$155.9M -$886K
Financing Cash Flow $1.71M $313.3M $309.8M
Net Change in Cash -$168.9M -$6.17M $211.1M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31
Net Income -$24.04M -$21.62M -$24.05M -$18.28M -$21.90M -$42.39M -$27.73M -$21.20M
Depreciation & Amortization $300K $300K $324K $317K $200K $200K $271K $247K
Stock-Based Compensation $4.54M $4.49M $4.28M $5.21M $4.74M $4.53M $4.67M $3.38M
Change in Payables $4.47M -$3.50M $3.98M -$614K $866K -$5.74M $3.78M $982K
Operating Cash Flow -$15.86M -$19.32M -$17.63M -$30.71M -$15.96M -$39.41M -$13.10M -$30.38M
Capital Expenditure -$160K -$50K -$19K -$235K -$937K -$329K -$344K -$788K
Free Cash Flow -$16.02M -$19.37M -$17.65M -$30.95M -$16.90M -$39.74M -$13.45M -$31.17M
Purchases of Investments -$40.31M -$41.98M -$45.83M -$42.77M -$134.2M -$32.77M -$93.36M -$155.0M
Investing Cash Flow $15.53M $21.97M $40.54M $11.00M -$38.51M $33.65M -$75.33M -$155.8M
Financing Cash Flow -- -- -- $0 $0 $1.71M $0 $305.0M
Net Change in Cash -$602K $1.72M $23.11M -$19.64M -$55.48M -$5.45M -$88.33M $119.2M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -42.4% -55.5% --
Return on Assets (ROA) -34.5% -46.0% -50.0%
Current Ratio 13.24x 26.48x 44.45x
Quick Ratio 12.81x 25.39x 40.86x
Debt to Equity 0.02x 0.01x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31
Return on Equity (ROE) -43.5% -38.7% -44.3% -42.4% -41.5% -35.7% -49.1% -55.5%
Return on Assets (ROA) -33.5% -30.8% -35.2% -34.5% -32.2% -28.1% -39.3% -46.0%
Current Ratio 10.06x 12.62x 11.42x 13.24x 14.72x 15.80x 15.35x 26.48x
Quick Ratio 9.84x 12.35x 11.05x 12.81x 14.15x 15.14x 14.67x 25.39x
Debt to Equity 0.01x 0.01x 0.02x 0.02x 0.02x 0.02x 0.01x 0.01x
Source: SEC EDGAR CompanyFacts (CIK 0001831283) · from December 31, 2020 Data through September 30, 2023 · synced Nov 21, 2026, 05:09 UTC · Open in terminal